642
Views
6
CrossRef citations to date
0
Altmetric
Clinical Studies

Association of metabolic changes with mortality of patients treated by peritoneal dialysis or hemodialysis

, , , , , & show all
Pages 778-783 | Received 15 Dec 2009, Accepted 21 Apr 2010, Published online: 21 Jul 2010

REFERENCES

  • Chung SH, Heimbürger O, Lindholm B, Lee HB. Peritoneal dialysis patient survival: A comparison between a Swedish and a Korean centre. Nephrol Dial Transplant. 2005;20:1207–1213.
  • Khawar O, Kalantar-Zadeh K, Lo WK, Johnson D, Mehrotra R. Is the declining use of long-term peritoneal dialysis justified by outcome data? Clin J Am Soc Nephrol. 2007;2:1317–1328.
  • James HG, Hans L, Melvin M. Initial survival advantage of peritoneal dialysis relative to hemodialysis. Nephrol Dial Transplant. 2002;17:112–117.
  • Segall L, Covic A. Cardiovascular disease in hemodialysis and peritoneal dialysis: Arguments pro hemodialysis. Nephrol Dial Transplant. 2007;22:59–63.
  • Gokal R. Peritoneal dialysis in the 21st century: An analysis of current problems and future developments. J Am Soc Nephrol. 2002;13(Suppl):S104–S115.
  • Stolic R, Trajkovic G, Peric V, Frequency and characteristics of metabolic disorders in patients on hemodialysis. Vojnosanit Pregl. 2008;65:205–209 (Serbian).
  • Winkelmayer WC, Glynn RJ, Mittleman MA, Levin R, Pliskin JS, Avorn J. Comparing mortality of elderly patients on hemodialysis versus peritoneal dialysis. A propensity score approach. J Am Soc Nephrol. 2002;13:2353–2362.
  • Couchoud C, Moranne O, Frimat L, Labeeuw M, Allot V, Stengel B. Associations between comorbidities, treatment choice and outcome in the elderly with end-stage renal disease. Nephrol Dial Transplant. 2007;22:3246–3254.
  • Kim SG, Kim NH. The effect of residual renal function at the initiation of dialysis on patient survival. Korean J Intern Med. 2009;24:55–62.
  • Portoles J, del Peso G, Fernandez-Reyes MJ, Bajo MA, Lopez-Sanchez P, The GCDP. Previous comorbidity and lack of patient free choice of technique predict early mortality in peritoneal dialysis. Perit Dial Int. 2009;29:150–157.
  • Termorshuizen F, Korevaar JC, Dekker FW, Hemodialysis and peritoneal dialysis: Comparison of adjusted mortality rates according to the duration of dialysis: Analysis of the Netherlands Cooperative Study on the Adequacy of Dialysis 2. J Am Soc Nephrol. 2003;14:2851–2860.
  • Sigrist M, Bungay P, Taal MW, McIntyre CW. Vascular calcification and cardiovascular function in chronic kidney disease. Nephrol Dial Transplant. 2006;21:707–714.
  • Bloembergen WE, Port FK, Mauger EA, Wolfe RA. A comparison of cause of death between patients treated with hemodialysis and peritoneal dialysis. J Am Soc Nephrol. 1995;6:184–191.
  • Van Biesen W, Verbeke F, Vanholder R. Cardiovascular disease in hemodialysis and peritoneal dialysis: Arguments pro peritoneal dialysis. Nephrol Dial Transplant. 2007;22:53–68.
  • Heaf JG, Lokkegaard H, Madsen M. Initial survival advantage of peritoneal dialysis relative to hemodialysis. Nephrol Dial Transplant. 2002;17:112–117.
  • Vonesh EF, Moran J. Mortality in end-stage renal disease: A reassessment of differences between patients treated with hemodialysis and peritoneal dialysis. J Am Soc Nephrol. 1999;10:354–365.
  • Inrig JK, Sun JL, Yang Q, Briley LP, Szczech LA. Mortality by dialysis modality among patients who have end-stage renal disease and are awaiting renal transplantation. Clin J Am Soc Nephrol. 2006;1:774–779.
  • Garcia-Lopes MG, Agliussi RG, Avesani CM, Nutritional status and body composition after 6 months of patients switching from continuous ambulatorial peritoneal dialysis to automated peritoneal dialysis. Braz J Med Biol Res. 2008;41:1116–1122.
  • Kalantar-Zadeh K, Kopple JD, Regidor DL, A1C and survival in maintenance hemodialysis patients. Diabetes Care. 2007;5:1049–1055.
  • Williams JD, Woods HF. Insulin resistance, the metabolic syndrome and renal failure – is there a special problem for patients treated with peritoneal dialysis? European Endocrine Review. 2006;29–34.
  • McDonald SP, Collins JF, Johnson DW. Obesity is associated with worse peritoneal dialysis outcomes in the Australia and New Zealand patient populations. J Am Soc Nephrol. 2003;14:2894–2901.
  • Haag-Weber M. The impact of residual diuresis on survival. Nephrol Dial Transplant. 2008;23:2123–2126.
  • Bargman JM, Golper TA. The importance of residual renal function for patients on dialysis. Nephrol Dial Transplant. 2005;20:671–673.
  • Moist LM, Port FK, Orzol SM, Predictors of loss of residual renal function among new dialysis patients. J Am Soc Nephrol. 2000;11:556–564.
  • Shemin D, Bostom, AG, Laliberty P, Dworkin LD. Residual renal function and mortality risk in hemodialysis patients. J Am Kidney Dis. 2001;38:85–90.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.